{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:24Z","timestamp":1791348624173,"version":"4.3.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05158-3","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:04:51Z","timestamp":1783746291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Obesity and diabetes associated with dysregulation of mevalonate pathway markers and progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor"],"prefix":"10.1186","volume":"17","author":[{"given":"Fereshteh","family":"Rezagholizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rokn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadhossein","family":"FakherBaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Taherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Azmoudeh-Ardalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud Baghai","family":"Wadji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Kashanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Eghtedari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Lotfalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sharifi-Zarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Taghi","family":"Joghataei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"5158_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2019.11.002","volume":"125","author":"AE Latenstein","year":"2020","unstructured":"Latenstein AE, van der Geest LG, Bonsing BA, Koerkamp BG, Mohammad NH, de Hingh IH, et al. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer. 2020;125:83\u201393.","journal-title":"Eur J Cancer"},{"issue":"10","key":"5158_CR2","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3390\/cancers14102417","volume":"14","author":"\u00c1 Sally","year":"2022","unstructured":"Sally \u00c1, McGowan R, Finn K, Moran BM. Current and future therapies for pancreatic ductal adenocarcinoma. Cancers. 2022;14(10):2417.","journal-title":"Cancers"},{"issue":"1","key":"5158_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000101873","volume":"7","author":"M Singh","year":"2007","unstructured":"Singh M, Maitra A. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology. 2007;7(1):9\u201319.","journal-title":"Pancreatology"},{"issue":"15","key":"5158_CR4","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1158\/1078-0432.CCR-14-2385","volume":"21","author":"V Rebours","year":"2015","unstructured":"Rebours V, Gaujoux S, d\u2019Assignies G, Sauvanet A, Ruszniewski P, L\u00e9vy P, et al. Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN). Clin Cancer Res. 2015;21(15):3522\u20138.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"5158_CR5","doi-asserted-by":"publisher","first-page":"e92282","DOI":"10.1172\/jci.insight.92282","volume":"2","author":"B Schludi","year":"2017","unstructured":"Schludi B, Moin ASM, Montemurro C, Gurlo T, Matveyenko AV, Kirakossian D, et al. Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes. JCI insight. 2017;2(13):e92282.","journal-title":"JCI insight"},{"key":"5158_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eclinm.2025.103297","volume":"85","author":"SF Moore","year":"2025","unstructured":"Moore SF, Price S, Konya J, Blummers S, Walter FM, Neal RD, et al. Risk factors for pancreatic cancer in electronic health records: an umbrella review of systematic reviews and meta-analyses. EClinicalMedicine. 2025;85:1.","journal-title":"EClinicalMedicine"},{"issue":"8","key":"5158_CR7","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41431-023-01301-3","volume":"31","author":"JG Maina","year":"2023","unstructured":"Maina JG, Pascat V, Zudina L, Ulrich A, Pupko I, Bonnefond A, et al. Abdominal obesity is a more important causal risk factor for pancreatic cancer than overall obesity. Eur J Hum Genet. 2023;31(8):962\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"5158_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13046-018-0963-4","volume":"37","author":"R Pothuraju","year":"2018","unstructured":"Pothuraju R, Rachagani S, Junker WM, Chaudhary S, Saraswathi V, Kaur S, et al. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. J Experimental Clin Cancer Res. 2018;37(1):319.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"10","key":"5158_CR9","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1200\/JCO.1994.12.10.2229","volume":"12","author":"S Hellman","year":"1994","unstructured":"Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994;12(10):2229\u201334.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5158_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148(1):349\u201361.","journal-title":"Cell"},{"issue":"18","key":"5158_CR11","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1158\/0008-5472.CAN-23-1045","volume":"84","author":"V Pita-Grisanti","year":"2024","unstructured":"Pita-Grisanti V, Velez-Bonet E, Chasser K, Hurst Z, Liette A, Vulic G, et al. Physical Activity Decreases Inflammation and Delays the Development of Obesity-Associated Pancreatic Ductal Adenocarcinoma. Cancer Res. 2024;84(18):3058\u201371.","journal-title":"Cancer Res"},{"issue":"2","key":"5158_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.molcel.2019.09.008","volume":"76","author":"R Riscal","year":"2019","unstructured":"Riscal R, Skuli N, Simon MC. Even cancer cells watch their cholesterol! Mol Cell. 2019;76(2):220\u201331.","journal-title":"Mol Cell"},{"issue":"6","key":"5158_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.trecan.2020.11.008","volume":"7","author":"D Juarez","year":"2021","unstructured":"Juarez D, Fruman DA. Targeting the mevalonate pathway in cancer. Trends cancer. 2021;7(6):525\u201340.","journal-title":"Trends cancer"},{"key":"5158_CR14","doi-asserted-by":"crossref","unstructured":"G\u00f6bel A, Rauner M, Hofbauer LC, Rachner TD. Cholesterol and beyond-The role of the mevalonate pathway in cancer biology. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2020;1873(2):188351.","DOI":"10.1016\/j.bbcan.2020.188351"},{"issue":"1","key":"5158_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/1878-0261.13716","volume":"19","author":"J Conde","year":"2025","unstructured":"Conde J, Fern\u00e1ndez-Pisonero I, Lorenzo\u2010Mart\u00edn LF, Garc\u00eda\u2010G\u00f3mez R, Casar B, Crespo P, et al. The mevalonate pathway contributes to breast primary tumorigenesis and lung metastasis. Mol Oncol. 2025;19(1):56\u201380.","journal-title":"Mol Oncol"},{"issue":"9","key":"5158_CR16","doi-asserted-by":"publisher","first-page":"e20192389","DOI":"10.1084\/jem.20192389","volume":"217","author":"TE Oni","year":"2020","unstructured":"Oni TE, Biffi G, Baker LA, Hao Y, Tonelli C, Somerville TD, et al. SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. J Exp Med. 2020;217(9):e20192389.","journal-title":"J Exp Med"},{"issue":"1","key":"5158_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, et al. Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment. Cell Metab. 2019;30(1):143\u2013e565.","journal-title":"Cell Metab"},{"issue":"7","key":"5158_CR18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.ccell.2023.04.016","volume":"41","author":"C Yan","year":"2023","unstructured":"Yan C, Zheng L, Jiang S, Yang H, Guo J, Jiang LY, et al. Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity. Cancer Cell. 2023;41(7):1276\u2013e9311.","journal-title":"Cancer Cell"},{"issue":"2","key":"5158_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmet.2017.01.016","volume":"25","author":"Z Li","year":"2017","unstructured":"Li Z, Kang Y. Lipid metabolism fuels cancer\u2019s spread. Cell Metabol. 2017;25(2):228\u201330.","journal-title":"Cell Metabol"},{"issue":"12","key":"5158_CR20","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cac2.12360","volume":"42","author":"X Yin","year":"2022","unstructured":"Yin X, Xu R, Song J, Ruze R, Chen Y, Wang C, et al. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun (Lond). 2022;42(12):1234\u201356.","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"5158_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41419-018-0330-6","volume":"9","author":"YA Wen","year":"2018","unstructured":"Wen YA, Xiong X, Zaytseva YY, Napier DL, Vallee E, Li AT, et al. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis. 2018;9(3):265.","journal-title":"Cell Death Dis"},{"issue":"9","key":"5158_CR22","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1158\/2767-9764.CRC-24-0120","volume":"4","author":"CT Ishida","year":"2024","unstructured":"Ishida CT, Myers SL, Kubota CS, Shao W, McGuire MR, Liu C, et al. SREBP-Dependent Regulation of Lipid Homeostasis Is Required for Progression and Growth of Pancreatic Ductal Adenocarcinoma. Cancer Res Commun. 2024;4(9):2539\u201352.","journal-title":"Cancer Res Commun"},{"issue":"8","key":"5158_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H, Fu M, Wu M, Cao Z, Zhang Q, Liu Z. Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Cell Death Dis. 2024;15(8):553.","journal-title":"Cell Death Dis"},{"issue":"11","key":"5158_CR24","doi-asserted-by":"publisher","first-page":"e70916","DOI":"10.1002\/cam4.70916","volume":"14","author":"Q Lin","year":"2025","unstructured":"Lin Q, Lin Y, Huang Y, Wang M, Xie X, Cai W, et al. Hepatitis B Virus X Protein Upregulates SREBP2 to Modulate Autophagy in Hepatocellular Carcinoma. Cancer Med. 2025;14(11):e70916.","journal-title":"Cancer Med"},{"issue":"2","key":"5158_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.32604\/or.2023.027112","volume":"31","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhou X, Li X, Huang D, Fang Z, Ding R. A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker. Oncol Res. 2023;31(2):193\u2013205.","journal-title":"Oncol Res"},{"issue":"571","key":"5158_CR26","doi-asserted-by":"publisher","first-page":"eaaz6667","DOI":"10.1126\/scitranslmed.aaz6667","volume":"12","author":"M Hao","year":"2020","unstructured":"Hao M, Hou S, Li W, Li K, Xue L, Hu Q, et al. Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Sci Transl Med. 2020;12(571):eaaz6667.","journal-title":"Sci Transl Med"},{"issue":"7596","key":"5158_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang W, Bai Y, Xiong Y, Zhang J, Chen S, Zheng X, et al. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature. 2016;531(7596):651\u20135.","journal-title":"Nature"},{"issue":"11","key":"5158_CR28","doi-asserted-by":"publisher","first-page":"12869","DOI":"10.18632\/oncotarget.7331","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, Wu JB, Li Q, Shigemura K, Chung LW, Huang WC. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget. 2016;7(11):12869\u201384.","journal-title":"Oncotarget"},{"issue":"1","key":"5158_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41420-021-00421-3","volume":"7","author":"H Xu","year":"2021","unstructured":"Xu H, Xia H, Zhou S, Tang Q, Bi F. Cholesterol activates the Wnt\/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer. Cell Death Discovery. 2021;7(1):38.","journal-title":"Cell Death Discovery"},{"issue":"2","key":"5158_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/1878-0261.12860","volume":"15","author":"DV Pham","year":"2021","unstructured":"Pham DV, Tilija Pun N, Park PH. Autophagy activation and SREBP-1 induction contribute to fatty acid metabolic reprogramming by leptin in breast cancer cells. Mol Oncol. 2021;15(2):657\u201378.","journal-title":"Mol Oncol"},{"key":"5158_CR31","doi-asserted-by":"publisher","first-page":"769647","DOI":"10.3389\/fphar.2021.769647","volume":"12","author":"T Zhu","year":"2021","unstructured":"Zhu T, Wang Z, Zou T, Xu L, Zhang S, Chen Y, et al. SOAT1 Promotes Gastric Cancer Lymph Node Metastasis Through Lipid Synthesis. Front Pharmacol. 2021;12:769647.","journal-title":"Front Pharmacol"},{"issue":"3","key":"5158_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","volume":"9","author":"A Carrer","year":"2019","unstructured":"Carrer A, Trefely S, Zhao S, Campbell SL, Norgard RJ, Schultz KC, et al. Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis. Cancer Discov. 2019;9(3):416\u201335.","journal-title":"Cancer Discov"},{"issue":"1","key":"5158_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/1078-0432.CCR-19-1543","volume":"26","author":"JM Karasinska","year":"2020","unstructured":"Karasinska JM, Topham JT, Kalloger SE, Jang GH, Denroche RE, Culibrk L, et al. Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer. Clin Cancer Res. 2020;26(1):135\u201346.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5158_CR34","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/gutjnl-2018-317706","volume":"68","author":"M Carlo","year":"2019","unstructured":"Carlo M, Sam RH, Jing H, Pasquale L, Tao S, Aqeel A, et al. Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes. Gut. 2019;68(6):1034.","journal-title":"Gut"},{"key":"5158_CR35","doi-asserted-by":"publisher","first-page":"101239","DOI":"10.1016\/j.gendis.2024.101239","volume":"12","author":"W Zhang","year":"2024","unstructured":"Zhang W, Zhang X, Teng F, Yang Q, Wang J, Sun B, et al. Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment. Genes Dis. 2024;12:101239.","journal-title":"Genes Dis"},{"issue":"4","key":"5158_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"5158_CR37","doi-asserted-by":"publisher","first-page":"1283364","DOI":"10.3389\/fimmu.2024.1283364","volume":"15","author":"F Rezagholizadeh","year":"2024","unstructured":"Rezagholizadeh F, Tajik F, Talebi M, Taha SR, Zadeh MS, Farhangnia P, et al. Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma. Front Immunol. 2024;15:1283364.","journal-title":"Front Immunol"},{"issue":"1","key":"5158_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12935-025-03810-1","volume":"25","author":"F Rezagholizadeh","year":"2025","unstructured":"Rezagholizadeh F, Salimi A, Sharifi-Zarchi A, Azmoudeh-Ardalan F, Mousavizadeh K, Tajik F, et al. Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated progression from pancreatic intraepithelial neoplasia to invasive pancreatic cancer. Cancer Cell Int. 2025;25(1):208.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"5158_CR39","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/PAI.0000000000001095","volume":"31","author":"P Price","year":"2023","unstructured":"Price P, Ganugapati U, Gatalica Z, Kakadekar A, Macpherson J, Quenneville L, et al. Reinventing Nuclear Histo-score Utilizing Inherent Morphologic Cutoffs: Blue-brown Color H-score (BBC-HS). Appl Immunohistochem Mol Morphol. 2023;31(7):500\u20136.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"5158_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun YS, Pawlik TM, Vauthey J-N. of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25:845\u20137.","journal-title":"Ann Surg Oncol"},{"key":"5158_CR41","doi-asserted-by":"crossref","unstructured":"Distler M, Aust D, Weitz J, Pilarsky C, Gr\u00fctzmann R. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. BioMed research international. 2014;2014(1):474905.","DOI":"10.1155\/2014\/474905"},{"key":"5158_CR42","doi-asserted-by":"publisher","first-page":"101828","DOI":"10.1016\/j.tranon.2023.101828","volume":"39","author":"Q Peng","year":"2024","unstructured":"Peng Q, Tao J, Xu Y, Shen Y, Wang Y, Jiao Y, et al. Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer. Translational Oncol. 2024;39:101828.","journal-title":"Translational Oncol"},{"key":"5158_CR43","doi-asserted-by":"crossref","unstructured":"Plebanek MP, Xue Y, Nguyen YV, DeVito NC, Wang X, Holtzhausen A et al. A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression. bioRxiv. 2023.","DOI":"10.1101\/2023.04.26.538456"},{"key":"5158_CR44","doi-asserted-by":"publisher","first-page":"896433","DOI":"10.3389\/fonc.2022.896433","volume":"12","author":"X Guo","year":"2022","unstructured":"Guo X, Zhou S, Yang Z, Li ZA, Hu W, Dai L, et al. Comprehensive Analysis of Sterol O-Acyltransferase 1 as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma. Front Oncol. 2022;12:896433.","journal-title":"Front Oncol"},{"issue":"1","key":"5158_CR45","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.1038\/s41467-023-43690-5","volume":"14","author":"Y Muta","year":"2023","unstructured":"Muta Y, Linares JF, Martinez-Ordo\u00f1ez A, Duran A, Cid-Diaz T, Kinoshita H, et al. Enhanced SREBP2-driven cholesterol biosynthesis by PKC\u03bb\/\u03b9 deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis. Nat Commun. 2023;14(1):8075.","journal-title":"Nat Commun"},{"issue":"1","key":"5158_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s40001-023-01547-z","volume":"28","author":"D Cao","year":"2023","unstructured":"Cao D, Liu H. Dysregulated cholesterol regulatory genes in hepatocellular carcinoma. Eur J Med Res. 2023;28(1):580.","journal-title":"Eur J Med Res"},{"issue":"10","key":"5158_CR47","first-page":"15","volume":"2025","author":"Y Gu","year":"2025","unstructured":"Gu Y, Zhang L, Li J, Ma E, Hu W, Du X, et al. Cholesterol esterification blockade boosts immunotherapy and reduces cancer relapse. bioRxiv. 2025;2025(10):15\u2013682531.","journal-title":"bioRxiv"},{"key":"5158_CR48","doi-asserted-by":"publisher","first-page":"1535691","DOI":"10.3389\/fphar.2025.1535691","volume":"16","author":"R Chen","year":"2025","unstructured":"Chen R, Chen T, Li X, Yu J, Lin M, Wen S, et al. SREBP2 as a central player in cancer progression: potential for targeted therapeutics. Front Pharmacol. 2025;16:1535691.","journal-title":"Front Pharmacol"},{"issue":"3","key":"5158_CR49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/cancers18030428","volume":"18","author":"Y Zhou","year":"2026","unstructured":"Zhou Y, Sharma V, Li X, Singla RK, Kumar A, Kyada A, et al. Targeting Pathways Implicated in Cholesterol Metabolism for Novel Cancer Therapy. Cancers. 2026;18(3):428.","journal-title":"Cancers"},{"issue":"6487","key":"5158_CR50","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.","journal-title":"Science"},{"issue":"11","key":"5158_CR51","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nrc.2016.85","volume":"16","author":"LB Sullivan","year":"2016","unstructured":"Sullivan LB, Gui DY, Heiden MGV. Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. Nat Rev Cancer. 2016;16(11):680\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5158_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","volume":"7","author":"Y Duan","year":"2022","unstructured":"Duan Y, Gong K, Xu S, Zhang F, Meng X, Han J. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Therapy. 2022;7(1):265.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"5158_CR53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang S, Zheng Y, Yang F, Zhu L, Zhu X-Q, Wang Z-F, et al. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduct Target Therapy. 2021;6(1):249.","journal-title":"Signal Transduct Target Therapy"},{"key":"5158_CR54","doi-asserted-by":"crossref","unstructured":"Fuller AM, Pruitt HC, Liu Y, Irizarry-Negron VM, Pan H, Song H et al. Oncogene-induced matrix reorganization controls CD8\u2009+\u2009T cell function in the soft-tissue sarcoma microenvironment. J Clin Invest. 2024;134(11).","DOI":"10.1172\/JCI167826"},{"issue":"50","key":"5158_CR55","doi-asserted-by":"publisher","first-page":"19306","DOI":"10.1074\/jbc.RA119.011160","volume":"294","author":"Y Xu","year":"2019","unstructured":"Xu Y, Du X, Turner N, Brown AJ, Yang H. Enhanced acyl-CoA:cholesterol acyltransferase activity increases cholesterol levels on the lipid droplet surface and impairs adipocyte function. J Biol Chem. 2019;294(50):19306\u201321.","journal-title":"J Biol Chem"},{"key":"5158_CR56","doi-asserted-by":"crossref","unstructured":"Dooley J, Lagou V, Goveia J, Ulrich A, Rohlenova K, Heirman N et al. Heterogeneous effects of calorie content and nutritional components underlie dietary influence on pancreatic cancer susceptibility. Cell Rep. 2020;32(2).","DOI":"10.1016\/j.celrep.2020.107880"},{"issue":"5","key":"5158_CR57","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2337\/db16-1477","volume":"66","author":"DK Andersen","year":"2017","unstructured":"Andersen DK, Korc M, Petersen GM, Eibl G, Li D, Rickels MR, et al. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes. 2017;66(5):1103\u201310.","journal-title":"Diabetes"},{"issue":"2","key":"5158_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/0008-5472.CAN-19-0650","volume":"80","author":"I Kaymak","year":"2020","unstructured":"Kaymak I, Maier CR, Schmitz W, Campbell AD, Dankworth B, Ade CP, et al. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress. Cancer Res. 2020;80(2):189\u2013203.","journal-title":"Cancer Res"},{"issue":"4","key":"5158_CR59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ncb2936","volume":"16","author":"G Sorrentino","year":"2014","unstructured":"Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, et al. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol. 2014;16(4):357\u201366.","journal-title":"Nat Cell Biol"},{"key":"5158_CR60","doi-asserted-by":"publisher","first-page":"215761","DOI":"10.1016\/j.canlet.2022.215761","volume":"542","author":"A G\u00f6bel","year":"2022","unstructured":"G\u00f6bel A, Riffel RM, Hofbauer LC, Rachner TD. The mevalonate pathway in breast cancer biology. Cancer Lett. 2022;542:215761.","journal-title":"Cancer Lett"},{"issue":"3","key":"5158_CR61","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","volume":"176","author":"S-H Moon","year":"2019","unstructured":"Moon S-H, Huang C-H, Houlihan SL, Regunath K, Freed-Pastor WA, Morris JP, et al. p53 represses the mevalonate pathway to mediate tumor suppression. Cell. 2019;176(3):564\u201380. e19.","journal-title":"Cell"},{"issue":"6","key":"5158_CR62","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/cells13060555","volume":"13","author":"Q Su","year":"2024","unstructured":"Su Q, Yao J, Farooq MA, Ajmal I, Duan Y, He C, et al. Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation. Cells. 2024;13(6):555.","journal-title":"Cells"},{"issue":"10","key":"5158_CR63","doi-asserted-by":"publisher","first-page":"e2211937120","DOI":"10.1073\/pnas.2211937120","volume":"120","author":"SS Mello","year":"2023","unstructured":"Mello SS, Flowers BM, Mazur PK, Lee JJ, M\u00fcller F, Denny SK, et al. Multifaceted role for p53 in pancreatic cancer suppression. Proc Natl Acad Sci USA. 2023;120(10):e2211937120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5158_CR64","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.omto.2020.01.008","volume":"16","author":"L Zhao","year":"2020","unstructured":"Zhao L, Liu Y, Zhao F, Jin Y, Feng J, Geng R, et al. Inhibition of Cholesterol Esterification Enzyme Enhances the Potency of Human Chimeric Antigen Receptor T Cells against Pancreatic Carcinoma. Mol Ther Oncolytics. 2020;16:262\u201371.","journal-title":"Mol Ther Oncolytics"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05158-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:02:29Z","timestamp":1791345749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05158-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5158"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05158-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted with ethical approval (Code: IR.IUMS.REC.1399.722) from the Iran University of Medical Sciences Research Ethics Committee. Informed consent was obtained from all patient participants before participation.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read the manuscript and provided their consent for the submission.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adobe Illustrator 2024 (v28.7.9.218) was used for the preparation and formatting of figures included in this manuscript.","order":3,"name":"Ethics","label":"Figure preparation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Evaluation of the expression of effective candidate invasive marker(s) resulting from RNA-sequencing and bioinformatic analysis and their associations with clinicopathologic features of patients with pancreatic cancer: A study using tissue microarrays (TMA).","order":4,"name":"Ethics","label":"Title of the approved project","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have not used AI-generated work in this manuscript.","order":5,"name":"Ethics","label":"Use of AI","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"357"}}